Samsung Biologics Expands Business Continuity Excellence with Additional ISO 22301 Certification |
| May 19, 2020 | May 2020 Bond Updates |
|
SONGDO, South Korea, May 19, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) announced it has attained ISO22301 certification for additional business operations, demonstrating its unsurpassed commitment to ensuring client satisfaction and operational excellence through its world-class... |
| View more at: https://www.prnewswire.com:443/news-releases/samsung-biologics-expands-business-continuity-excellence-with-additional-iso-22301-certification-301061399.html |
| Related News |